Brown Advisory Inc Novo Nordisk A S Transaction History

Brown Advisory Inc

$77.3 Billion
Q3 2024

A detailed history of Brown Advisory Inc transactions in Novo Nordisk A S stock. As of the latest transaction made, Brown Advisory Inc holds 111,954 shares of NVO stock, worth $12.1 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

111,954

Previous 114,991 2.64%

Holding current value

$12.1 Million

Previous $16.4 Million 18.78%

% of portfolio

0.02%

Previous 0.02%

33 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$119.07 - $145.42 $361,615 - $441,640	-3,037 Reduced 2.64%	111,954 $13.3 Million
Q2 2024 Aug 14, 2024	BUY	$122.71 - $146.91 $666,683 - $798,162	5,433 Added 4.96%	114,991 $16.4 Million
Q1 2024 Apr 24, 2024	BUY	$102.11 - $135.92 $267,323 - $355,838	2,618 Added 2.45%	109,558 $14.1 Million
Q4 2023 Feb 08, 2024	SELL	$87.78 - $105.45 $80,757 - $97,014	-920 Reduced 0.85%	106,940 $11.1 Million
Q3 2023 Oct 24, 2023	BUY	$90.94 - $199.54 $4.8 Million - $10.5 Million	52,830 Added 96.0%	107,860 $9.81 Million
Q2 2023 Jul 31, 2023	BUY	$155.98 - $172.65 $285,443 - $315,949	1,830 Added 3.44%	55,030 $8.91 Million
Q1 2023 May 08, 2023	BUY	$132.34 - $159.14 $277,649 - $333,875	2,098 Added 4.11%	53,200 $8.47 Million
Q4 2022 Feb 13, 2023	BUY	$102.55 - $135.33 $9,947 - $13,127	97 Added 0.19%	51,102 $6.92 Million
Q3 2022 Nov 14, 2022	BUY	$95.28 - $116.93 $85,370 - $104,769	896 Added 1.79%	51,005 $5.08 Million
Q2 2022 Nov 14, 2022	SELL	$103.24 - $121.81 $25,810 - $30,452	-250 Reduced 0.5%	50,109 $5.58 Million
Q2 2022 Aug 02, 2022	SELL	$103.24 - $121.81 $25,293 - $29,843	-245 Reduced 0.49%	49,303 $5.49 Million
Q1 2022 Nov 14, 2022	BUY	$93.1 - $112.54 $98,313 - $118,842	1,056 Added 2.14%	50,359 $5.59 Million
Q1 2022 May 09, 2022	BUY	$93.1 - $112.54 $4.15 Million - $5.02 Million	44,619 Added 905.23%	49,548 $5.5 Million
Q4 2021 Jan 27, 2022	SELL	$95.88 - $117.08 $30,681 - $37,465	-320 Reduced 6.1%	4,929 $552,000
Q3 2021 Nov 12, 2021	SELL	$84.42 - $106.62 $77,159 - $97,450	-914 Reduced 14.83%	5,249 $504,000
Q2 2021 Jul 29, 2021	SELL	$67.66 - $84.76 $21,380 - $26,784	-316 Reduced 4.88%	6,163 $515,000
Q1 2021 May 14, 2021	BUY	$67.06 - $75.82 $48,685 - $55,045	726 Added 12.62%	6,479 $437,000
Q4 2020 Feb 12, 2021	BUY	$63.89 - $73.8 $42,359 - $48,929	663 Added 13.03%	5,753 $401,000
Q3 2020 Nov 16, 2020	SELL	$63.69 - $70.22 $27,832 - $30,686	-437 Reduced 7.91%	5,090 $353,000
Q2 2020 Aug 14, 2020	SELL	$58.54 - $67.94 $2,165 - $2,513	-37 Reduced 0.66%	5,527 $362,000
Q1 2020 May 15, 2020	SELL	$49.46 - $64.78 $1,978 - $2,591	-40 Reduced 0.71%	5,564 $335,000
Q4 2019 Feb 14, 2020	BUY	$49.86 - $58.26 $279,415 - $326,489	5,604 New	5,604 $324,000
Q3 2019 Nov 14, 2019	SELL	$47.54 - $53.43 $288,853 - $324,640	-6,076 Closed	0 $0
Q2 2019 Aug 12, 2019	SELL	$46.79 - $52.47 $336,934 - $377,836	-7,201 Reduced 54.24%	6,076 $310,000
Q1 2019 May 15, 2019	SELL	$46.36 - $52.63 $33,750 - $38,314	-728 Reduced 5.2%	13,277 $694,000
Q4 2018 Feb 13, 2019	SELL	$41.54 - $47.25 $9,388 - $10,678	-226 Reduced 1.59%	14,005 $645,000
Q3 2018 Nov 13, 2018	SELL	$46.76 - $51.24 $27,635 - $30,282	-591 Reduced 3.99%	14,231 $670,000
Q2 2018 Aug 10, 2018	SELL	$44.29 - $50.42 $561,198 - $638,871	-12,671 Reduced 46.09%	14,822 $684,000
Q1 2018 Jun 28, 2018	BUY	$48.49 - $58.14 $25,408 - $30,465	524 Added 1.94%	27,493 $1.35 Million
Q1 2018 May 14, 2018	SELL	$48.49 - $58.14 $24,438 - $29,302	-504 Reduced 1.83%	26,969 $1.33 Million
Q4 2017 Feb 12, 2018	SELL	$47.53 - $53.73 $52,900 - $59,801	-1,113 Reduced 3.89%	27,473 $1.48 Million
Q3 2017 Nov 13, 2017	SELL	$41.15 - $49.22 $105,467 - $126,150	-2,563 Reduced 8.23%	28,586 $1.38 Million
Q2 2017 Aug 14, 2017	BUY	N/A	31,149	31,149 $1.34 Million

Others Institutions Holding NVO

# of Institutions

1,956

Shares Held

320M

Call Options Held

5.49M

Put Options Held

7.78M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $244B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Brown Advisory Inc, based on Form 13F filings with the SEC.

News

Stay updated on Brown Advisory Inc with notifications on news.

Account

Brown Advisory Inc Novo Nordisk A S Transaction History